MOLN Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 июнь 2024 @ 23:00):
Our systems believe the stock currently is undervalued by 0.09% compare to its pairs and should correct upwards.

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins...

Stats
Объем за сегодня	4 489
Средний объем	26 467
Рыночная капитализация	239.91M
EPS	$-0.340 ( Q1 \| 2024-05-17 )
Дата следующего отчета о доходах	( $-1.410 ) 2024-08-28
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.63 (Sector) 42.63 (Industry) 24.32
ATR14	$0.133 (1.84%)

AADI -10.43%

ABCL 2.78%

ABCM 0.04%

ABEO 1.19%

ABIO 6.39%

ABOS 2.54%

ABSI 0.98%

ABUS -0.32%

ABVX 3.69%

ACAD -0.73%

ACER -17.95%

ACET -9.70%

ACGN 1.29%

ACHL 0.62%

ACHV 1.29%

ACIU 0.50%

ACLX 1.98%

ACRV 0.69%

ACST -2.67%

ACXP -2.60%

ADAG 6.66%

ADAP -0.60%

ADGI 0.87%

ADIL 1.77%

ADMA 2.10%

ADPT 4.62%

ADTX -2.84%

ADVM -1.72%

ADXN -3.06%

AEON -0.94%

AEZS -2.64%

AFMD 0.00%

AGEN 18.63%

AGIO -1.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 3.11%

AKRO 0.26%

AKTX 0.75%

AKUS 0.00%

ALBO 0.00%

ALDX -2.65%

ALEC 0.00%

ALGS -7.51%

ALKS -0.78%

ALLK -5.66%

ALLO -4.51%

ALLR 3.85%

ALNA 3.16%

ALNY -1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -4.48%

ALT 4.15%

ALVR -7.27%

ALXN 0.00%

ALXO 3.34%

ALZN -0.65%

AMRN -1.84%

AMTI -3.13%

ANAB 1.05%

ANEB 3.80%

ANGN 0.00%

ANIX -7.14%

ANL -6.05%

ANNX 1.66%

ANPC -3.15%

APGE -1.50%

APGN 8.48%

APGNW 30.65%

APLM 1.30%

APLS -7.61%

APLT 1.52%

APM -5.26%

APOP 0.38%

APRE -0.49%

APTO 1.20%

APTX 3.17%

APVO -40.57%

ARAV -13.39%

ARCT -0.41%

ARDS -17.87%

ARDX 14.00%

ARGX -3.35%

ARNA 0.00%

ARPO -0.90%

ARQT -1.27%

ARTL 3.08%

ARTLW 0.00%

ARVN 2.98%

ARWR 1.17%

ASLN 4.90%

ASMB -6.03%

ASND 0.72%

ATAI 0.76%

ATHA 0.38%

ATHE 0.56%

ATHX -33.50%

ATNF 9.27%

ATOS 4.39%

ATRA 2.91%

ATXI -2.23%

ATXS -1.30%

AUPH 1.60%

AURA 3.85%

AUTL 4.50%

AVBP 6.61%

AVEO 0.00%

AVIR -2.07%

AVRO -1.41%

AVTE -0.60%

AVTX -5.53%

AVXL -1.63%

AXLA 0.00%

AXSM 0.51%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB -6.80%

BCDA -0.34%

BCDAW 0.00%

BCEL 0.00%

BCLI -6.08%

BCRX 1.15%

BCTX 9.62%

BCTXW 1.47%

BCYC -0.15%

BDRX 2.98%

BDTX -0.85%

BEAM -2.29%

BFRA -2.91%

BGNE -2.00%

BIOR 2.37%

BIVI -10.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.37%

BLTE -1.76%

BLU 0.03%

BLUE 3.74%

BMEA -0.66%

BMRN -1.40%

BNOX 3.51%

BNTC -0.71%

BNTX -0.02%

BOLD -14.76%

BOLT 0.32%

BPMC -0.68%

BPTH 2.56%

BPTS -13.47%

BRNS 1.45%

BRTX 10.93%

BTAI 0.79%

BTTX 30.91%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.44%

CABA 1.91%

CADL 5.26%

CALA 0.00%

CALC 25.71%

CALT 0.72%

CAPR 2.80%

CARA -15.27%

CARM 18.75%

CASI 12.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 3.79%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO 0.37%

CDIOW 21.56%

CDMO 1.85%

CDMOP 0.04%

CDT 3.92%

CDTTW -12.92%

CDTX 6.70%

CDXC 3.02%

CDXS 2.99%

CELC 0.68%

CELU 11.79%

CELUW 0.00%

CERC -1.68%

CERE 0.96%

CERO -1.77%

CEROW 43.57%

CFRX -27.95%

CGEM 2.05%

CGEN -4.55%

CGON 4.36%

CGTX -0.60%

CHMA -6.00%

CHRS 1.76%

CINC 0.00%

CING -45.21%

CINGW 4.85%

CKPT 4.37%

CLBS -16.75%

CLDX -1.80%

CLGN -0.60%

CLLS 0.54%

CLNN -3.47%

CLNNW 3.32%

CLRB 7.30%

CLSD 1.56%

CLSN -0.68%

CLVS 0.00%

CMMB -4.26%

CMND 25.37%

CMPI 0.00%

CMPX -16.67%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.47%

CNCE 0.00%

CNSP -4.82%

CNST 0.00%

CNTA 0.56%

CNTB 18.75%

CNTX -0.25%

COCP -8.63%

COEPW 0.00%

COGT -0.12%

CORT 1.34%

COYA -0.49%

CPRX 2.99%

CRBP 3.12%

CRBU -2.38%

CRDF -4.72%

CRGX 4.99%

CRIS -7.38%

CRNX 3.04%

CRSP -2.47%

CRTX 2.63%

CRVO -0.29%

CRVS -2.67%

CSBR 0.39%

CTCX 9.02%

CTIC 0.06%

CTMX -3.17%

CTNM -6.08%

CTXR -8.54%

CUE -11.43%

CVAC 1.19%

CVKD 1.82%

CWBR 0.00%

CYAD -12.96%

CYCC -4.71%

CYCCP -11.68%

CYCN 5.99%

CYT -2.27%

CYTK 0.74%

CYTO 0.00%

DARE -8.79%

DAWN -0.36%

DBTX -0.81%

DBVT -5.53%

DFFN 10.28%

DICE 0.06%

DMAC -3.28%

DNLI 1.09%

DNTH 3.85%

DOMH -1.58%

DRMA 4.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 23.41%

DRTSW -8.84%

DRUG 2.32%

DSGN 0.00%

DTIL 3.29%

DYAI -6.33%

EARS -1.77%

EDIT -1.48%

EDSA -2.51%

EFTR -6.42%

EFTRW 0.00%

EIGR -9.21%

ELAB -1.48%

ELDN 1.54%

ELEV 7.57%

ELOX 12.20%

ELTX -40.35%

ELVN -0.34%

ELYM -5.58%

ENGN 5.13%

ENGNW -0.83%

ENLV -4.70%

ENOB 1.79%

ENSC -2.78%

ENTA 2.37%

ENTO 2.51%

ENTX -5.64%

ENVB 0.71%

EPIX 1.54%

EPRX 0.78%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.16%

ERNA 5.17%

ERYP 1.30%

ESLA 12.90%

ESLAW 0.00%

ETNB 6.23%

ETON -0.90%

ETTX 0.00%

EVAX 1.05%

EVGN -5.74%

EVLO -99.83%

EWTX 2.91%

EXAI -2.30%

EXEL -0.27%

EYEG -0.50%

EYEN -14.16%

EYPT -0.57%

FATE 0.46%

FBIO 1.79%

FBIOP 1.02%

FBLG 7.08%

FBRX -2.01%

FDMT 0.29%

FENC -0.65%

FGEN -13.37%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 13.22%

FOLD 0.10%

FREQ 4.76%

FRLN 0.15%

FRTX 5.56%

FSTX 0.00%

FTRE 2.01%

FULC -1.27%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 2.73%

GANX 2.40%

GBIO -1.05%

GBT 0.01%

GDTC 5.05%

GERN -4.50%

GHRS -2.75%

GLMD 2.46%

GLPG -1.43%

GLSI 2.25%

GLTO -5.16%

GLUE 10.65%

GLYC -11.22%

GMAB -1.76%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -6.48%

GNLX -11.36%

GNPX -3.33%

GNTA -0.32%

GOSS -5.38%

GOVX -10.28%

GOVXW -20.59%

GPCR 0.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -12.42%

GRTX 1.33%

GTHX 1.33%

GUTS -3.61%

GXGXW 41.67%

GYRE 20.63%

HALO 1.41%

HARP 0.09%

HCWB 1.06%

HEPA -5.55%

HGEN -84.62%

HILS 5.66%

HLVX 8.15%

HOOK -8.97%

HOTH -0.79%

HOWL -2.79%

HRMY -4.16%

HRTX 2.64%

HSTO 0.00%

HUMA 2.13%

HUMAW -1.42%

IBRX -3.36%

ICCC 11.24%

ICPT 0.21%

ICU 10.16%

ICUCW 12.50%

ICVX -0.91%

IDRA -23.04%

IDYA 2.15%

IFRX 4.19%

IGMS 3.93%

IKNA -5.71%

IKT -12.32%

IMAB -1.18%

IMCR 0.33%

IMGN 0.02%

IMGO 0.00%

IMMP 7.49%

IMMX -7.04%

IMNM 1.09%

IMNN 0.87%

IMPL -27.27%

IMRA 15.96%

IMRN -3.97%

IMRX -10.49%

IMTX -1.44%

IMTXW 2.21%

IMUX 8.82%

IMV 0.00%

IMVT 1.54%

INAB -5.87%

INBX 0.78%

INCY -1.19%

INDP -7.02%

INFI -52.38%

INKT 2.06%

INM 0.19%

INMB 1.50%

INO 4.12%

INSM 0.07%

INTS 0.20%

INVA 1.23%

INZY -1.33%

IOBT -0.85%

IONS 0.91%

IOVA 0.12%

IPA 1.23%

IPHA -1.52%

IPSC 0.79%

IRON 1.62%

ISEE 0.38%

ITOS -4.26%

ITRM -4.58%

IVA -0.33%

IVVD -8.33%

JAGX -1.11%

JANX 3.84%

JAZZ -0.35%

JNCE 0.00%

JSPR 3.13%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA -5.43%

KALV -2.24%

KDNY 0.22%

KMPH -0.34%

KNSA 0.43%

KNTE -0.38%

KOD -3.29%

KPRX 1.20%

KPTI -10.84%

KRBP 6.83%

KRON 3.33%

KROS 1.40%

KRRO 1.20%

KRTX 0.03%

KRYS 0.42%

KTRA -3.60%

KTTA 1.62%

KTTAW 0.92%

KURA 0.44%

KYMR -1.22%

KYTX 1.90%

KZIA 2.65%

KZR -5.41%

LABP 0.57%

LBPH 20.19%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.83%

LENZ -2.92%

LEXX 5.70%

LEXXW -5.15%

LGND 2.34%

LGNDV 0.00%

LGVN -4.17%

LIAN -8.28%

LIFE 2.70%

LIPO -3.43%

LIXT -2.47%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -2.06%

LPCN 6.32%

LPTX 10.73%

LQDA -3.07%

LRMR -1.36%

LSTA -0.57%

LTRN 2.86%

LUMO 2.20%

LVTX -3.74%

LXEO 7.94%

LXRX -3.45%

LYEL 5.07%

LYRA 5.93%

MACK 0.10%

MBIO 1.59%

MBRX -3.83%

MCRB -7.80%

MDGL -1.93%

MDNA -13.16%

MDWD 4.30%

MDXG 2.51%

MEIP -1.36%

MESO -0.58%

MGNX 3.16%

MGTA -7.74%

MGTX -0.47%

MGX 8.22%

MIRM 3.26%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC 1.85%

MLECW -28.57%

MLND -5.36%

MLTX 5.47%

MLYS 1.74%

MNKD -1.32%

MNMD -0.55%

MNOV 0.00%

MNPR -1.67%

MOLN 4.33%

MOR 0.17%

MORF 0.18%

MREO 3.45%

MRKR 12.42%

MRNA -2.01%

MRNS -4.88%

MRSN 0.75%

MRTX -0.17%

MRUS -1.71%

MRVI 1.13%

MTCR -1.29%

MTEM 3.60%

MTP -18.50%

MURA 2.28%

MYMD -1.08%

NAMS -1.69%

NAMSW -3.11%

NAUT 2.63%

NBRV 0.71%

NBSE -1.56%

NBTX -10.71%

NCNA -4.49%

NERV 4.59%

NEXI 0.00%

NGM -1.28%

NGNE 4.51%

NKGN 2.42%

NKGNW -12.00%

NKTR 8.77%

NKTX 0.85%

NLSP -9.63%

NLSPW 7.48%

NMRA 6.85%

NMTR -42.97%

NOVN -24.84%

NRBO 0.83%

NRIX 0.63%

NRSN 9.80%

NRSNW 21.18%

NRXP -6.87%

NRXPW -16.53%

NRXS 4.51%

NTBL -6.32%

NTEC -12.45%

NTHI 0.00%

NTLA -3.49%

NTRBW 74.65%

NUVL -1.44%

NVAX -1.33%

NVCT 0.96%

NVIV -34.28%

NXTC -3.05%

NYMX -0.05%

OABI -0.53%

OABIW 6.37%

OBIO 2.77%

OBSV 0.00%

OCEA -11.59%

OCGN 8.39%

OCS 1.44%

OCUL 1.18%

OCUP 0.66%

ODT -4.27%

OKYO 0.85%

OLMA -3.48%

OMER 2.78%

OMGA -7.59%

ONCO -18.40%

ONCR -3.08%

ONCS 31.87%

ONCT -1.17%

ONCY -1.98%

ONTX -0.47%

ONVO -0.41%

OPNT 0.00%

OPT 3.21%

ORGS -5.36%

ORIC 2.32%

ORMP -4.10%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.73%

OVID 5.89%

OYST 0.00%

PALI -1.53%

PASG -14.04%

PBLA 11.11%

PBM -8.81%

PBYI 0.93%

PCSA 8.21%

PCVX -4.14%

PDSB -2.66%

PEPG -3.04%

PGEN 4.64%

PHAR 3.47%

PHAS 0.00%

PHAT -0.96%

PHIO 1.75%

PHIOW 36.47%

PHVS 4.39%

PHXM -5.20%

PIRS 5.83%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.84%

PLUR 7.04%

PMN -1.96%

PMVP -2.41%

PNT 0.16%

PPBT -6.42%

PRAX 4.02%

PRDS 0.93%

PRLD 3.25%

PROG -3.47%

PROK 1.65%

PRQR 0.61%

PRTA 0.54%

PRTC 4.56%

PRTG -6.11%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.34%

PSTX 7.35%

PTCT -11.77%

PTE -0.82%

PTGX 8.69%

PTIXW -47.77%

PULM 0.52%

PXMD -9.45%

PYPD 3.12%

PYXS 3.12%

QLGN -3.31%

QNCX 4.87%

QNRX -2.85%

QSI 11.70%

QSIAW 4.08%

QTTB 17.70%

QURE -1.32%

RAIN -1.63%

RANI -3.55%

RAPT 5.54%

RARE -0.77%

RCKT 0.47%

REGN 0.02%

RENB 16.67%

REPL 5.63%

RETA 0.02%

REUN -0.89%

REVB 2.69%

REVBU 3.46%

REVBW 19.05%

RGLS -11.85%

RGNX 0.60%

RIGL -13.75%

RLAY 3.49%

RLMD 0.33%

RLYB -9.46%

RNA 0.76%

RNAC -5.29%

RNAZ -0.50%

RNXT -2.59%

ROIV 0.00%

ROIVW 4.56%

RPHM -6.21%

RPRX -1.12%

RPTX -2.37%

RUBY 2.70%

RVLP -32.05%

RVMD 0.73%

RVMDW 45.86%

RVNC -0.39%

RVPH 0.00%

RVPHW 1.89%

RXDX 0.09%

RXRX -0.99%

RYTM 2.32%

RYZB 0.02%

RZLT 7.23%

SABS 6.16%

SABSW 35.43%

SAGE 1.59%

SANA 1.11%

SAVA -34.83%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -2.80%

SCPH -0.46%

SCPS 0.00%

SEEL -2.10%

SEER -4.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -10.11%

SGMT -16.79%

SGTX -2.56%

SIOX 22.63%

SLDB -1.22%

SLGL 3.37%

SLN 0.00%

SLNO -2.28%

SLRX -2.86%

SLS 4.39%

SMMT -0.89%

SNDX 1.03%

SNGX -7.19%

SNPX 0.99%

SONN -1.41%

SPPI -0.49%

SPRB -2.72%

SPRC -5.99%

SPRO -2.99%

SRNE 5.26%

SRPT 0.03%

SRRA 0.00%

SRRK -0.36%

SRZN 10.16%

STAB 0.00%

STOK 1.50%

STRO 0.34%

STSA 0.00%

STTK 2.93%

SURF -0.93%

SVRA 5.77%

SWTX 0.37%

SYBX -1.96%

SYRS -9.95%

TALS -0.73%

TARA -4.15%

TARS 7.99%

TBPH 1.80%

TCBP -1.31%

TCDA 0.00%

TCON -1.38%

TCRR 0.00%

TCRT -2.92%

TCRX -6.25%

TECH -0.24%

TENX 1.17%

TERN -4.22%

TFFP 3.11%

TGTX -0.89%

THRX 0.12%

TIL -1.06%

TLC 0.00%

TLSA 4.43%

TNGX 0.47%

TNXP 1.07%

TNYA 5.44%

TPST 0.92%

TRDA 0.56%

TRVI 1.36%

TRVN 1.40%

TSHA 3.46%

TSVT 2.39%

TTNP 0.91%

TVTX -0.72%

TYRA 3.50%

UBX -2.17%

UNCY 23.70%

URGN -1.12%

UTHR 0.51%

VACC 11.36%

VALN -5.14%

VAXX -0.24%

VBIV 1.54%

VBLT -8.77%

VCEL -2.20%

VCNX 2.69%

VCYT -1.46%

VERA 4.39%

VERU 5.16%

VERV 2.52%

VIGL -10.71%

VINC 9.46%

VIR 0.34%

VIRI -8.20%

VIRX -5.93%

VKTX 4.41%

VLON -13.04%

VNDA -2.75%

VOR -12.28%

VRCA 0.97%

VRDN 1.80%

VRNA -6.35%

VRPX -0.52%

VRTX -0.80%

VSTM 2.76%

VTGN 0.00%

VTVT -0.34%

VTYX -3.35%

VXRT 0.20%

VYGR 0.64%

VYNE 0.00%

VYNT 7.78%

WINT -3.60%

WVE 0.00%

XBIO 1.50%

XBIT 11.50%

XCUR 5.89%

XENE 4.22%

XERS -0.44%

XFOR -13.45%

XLO 0.80%

XLRN 0.00%

XNCR -1.41%

XOMA 3.45%

XOMAO 0.24%

XOMAP 0.08%

XRTX 0.00%

YMAB -2.03%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.08%

ZNTL -2.62%

ZSAN 0.00%

Корреляция (AI algo v.1.1b): Undervalued: 0.09% $7.24 paired level. (Алгоритм отслеживает изменения наиболее коррелирующих акций в режиме реального времени и дает мгновенное обновление)

Molecular Partners AG Корреляция

10 Самые положительные корреляции
GTEC	0.891
DRUG	0.89
DLHC	0.88
AEI	0.874
TELA	0.874
SAGE	0.873
ZS	0.871
LBTYK	0.869
IMCR	0.868
DMRC	0.867

10 Самые отрицательные корреляции
BZ	-0.84
LFMD	-0.84
HWKN	-0.839
MMLP	-0.838
IGLD	-0.837
KALU	-0.837
GERN	-0.833
SLVO	-0.829
KNTK	-0.828
JAN	-0.827

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Molecular Partners AG Финансовые показатели

Annual	2023
Выручка:	$7.04M
Валовая прибыль:	$-40.81M (-579.80 %)
EPS:	$-1.890

FY	2023
Выручка:	$7.04M
Валовая прибыль:	$-40.81M (-579.80 %)
EPS:	$-1.890

FY	2022
Выручка:	$189.56M
Валовая прибыль:	$138.81M (73.23 %)
EPS:	$3.63

FY	2021
Выручка:	$9.33M
Валовая прибыль:	$0.00 (0.00 %)
EPS:	$-2.06

Financial Reports:

No articles found.

Molecular Partners AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Molecular Partners AG

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.